Teicoplanin allergy - an emerging problem in the anaesthetic allergy clinic.
L C Savic, T Garcez, P M Hopkins...
https://pubmed.ncbi.nlm.nih.gov/26385667/Actively Recruiting
Led by University Hospital Southampton NHS Foundation Trust · Updated on 2025-01-31
20
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are investigating why allergy skin testing for Teicoplanin is less reliable compared to other similar drugs, which risks missing serious allergic reactions that can be life threatening. The study focuses on patients who have experienced anaphylaxis during general anesthesia where Teicoplanin was used. The goal is to find a better testing method to identify Teicoplanin allergies and improve patient safety. The trial involves 20 adult patients who experienced anaphylaxis during anesthesia and received Teicoplanin. In addition to the standard allergy skin test, researchers will perform extra skin tests using the patients own serum mixed with Teicoplanin. This autologous serum test is done during the same routine allergy appointment and aims to see if this method detects allergies more reliably than the usual skin test. Participants will undergo skin prick and intradermal testing with several sample types, including Teicoplanin mixed with blood before and after centrifugation and a serum control. Researchers will measure whether using autologous serum results in more positive allergy tests over two years. Throughout the study, safety and reaction monitoring will be conducted as part of the routine allergy evaluation process.
CONDITIONS
Teicoplanin Allergy Testing Using Autologous Serum (TATAS)
L
Linda Nel, MB BCh FRCA
X
Xi Ying Soo, MBBS
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University Hospital Southampton NHS Foundation Trust
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit (in-person)
Duration - 1 day
Participants undergo teicoplanin allergy skin testing using standard and autologous serum methods during a routine elective allergy skin-testing appointment.
1 visit (in-person)
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Have more questions? Get in touch with our team for quick support
L C Savic, T Garcez, P M Hopkins...
https://pubmed.ncbi.nlm.nih.gov/26385667/G Liccardi, G D'Amato, G Walter Canonica...
https://pubmed.ncbi.nlm.nih.gov/16689179/University Hospital Southampton NHS Foundation Trust
Lead Sponsor